AC
SHPH icon

Armistice Capital’s Shuttle Pharmaceuticals SHPH Stock Holding History

Armistice Capital’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-282
Closed -$27.4K – 259
2025
Q1 		$27.4K Sell
282
-942
-77% -$153K ﹤0.01% 216
2024
Q4 		$263K Buy
+1,224
New +$319K ﹤0.01% 189

Other funds holding SHPH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Armistice Capital's SHPH Position: Q2 2025 in Review

Armistice Capital sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2025, closing a stake of 282 shares — an estimated $27.4K sold.

Armistice Capital first reported a position in SHPH in Q4 2024 and held it in 2 quarters. The position peaked at $263K in Q4 2024. 3 funds tracked by Wall St. Rank hold SHPH as of Q2 2025.

  • Armistice Capital reported no remaining Shuttle Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 282 Shuttle Pharmaceuticals shares in Q2 2025, an estimated $27.4K.
  • Armistice Capital first reported a position in Shuttle Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Armistice Capital's Shuttle Pharmaceuticals position peaked at $263K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.